| Genetic studies of body mass index yield new insights for obesity biology AE Locke, B Kahali, SI Berndt, AE Justice, TH Pers, FR Day, C Powell, ... Nature 518 (7538), 197-206, 2015 | 5013 | 2015 |
| Defining the role of common variation in the genomic and biological architecture of adult human height AR Wood, T Esko, J Yang, S Vedantam, TH Pers, S Gustafsson, AY Chu, ... Nature genetics 46 (11), 1173-1186, 2014 | 2206 | 2014 |
| New genetic loci link adipose and insulin biology to body fat distribution D Shungin, TW Winkler, DC Croteau-Chonka, T Ferreira, AE Locke, ... Nature 518 (7538), 187-196, 2015 | 1744 | 2015 |
| PheWAS: demonstrating the feasibility of a phenome-wide scan to discover gene–disease associations JC Denny, MD Ritchie, MA Basford, JM Pulley, L Bastarache, ... Bioinformatics 26 (9), 1205-1210, 2010 | 1259 | 2010 |
| Systematic comparison of phenome-wide association study of electronic medical record data and genome-wide association study data JC Denny, L Bastarache, MD Ritchie, RJ Carroll, R Zink, JD Mosley, ... Nature biotechnology 31 (12), 1102-1111, 2013 | 1085 | 2013 |
| FMR1 and the fragile X syndrome: human genome epidemiology review DC Crawford, JM Acuņa, SL Sherman Genetics in Medicine 3 (5), 359-371, 2001 | 855 | 2001 |
| Quality control procedures for genome‐wide association studies S Turner, LL Armstrong, Y Bradford, CS Carlson, DC Crawford, ... Current protocols in human genetics 68 (1), 1.19. 1-1.19. 18, 2011 | 514 | 2011 |
| Definition and clinical importance of haplotypes DC Crawford, DA Nickerson Annu. Rev. Med. 56, 303-320, 2005 | 504 | 2005 |
| Operational implementation of prospective genotyping for personalized medicine: the design of the Vanderbilt PREDICT project JM Pulley, JC Denny, JF Peterson, GR Bernard, CL Vnencak‐Jones, ... Clinical Pharmacology & Therapeutics 92 (1), 87-95, 2012 | 438 | 2012 |
| Warfarin pharmacogenetics: a single VKORC1 polymorphism is predictive of dose across 3 racial groups NA Limdi, M Wadelius, L Cavallari, N Eriksson, DC Crawford, MTM Lee, ... Blood 115 (18), 3827-3834, 2010 | 413 | 2010 |
| Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction DV Conti, BF Darst, LC Moss, EJ Saunders, X Sheng, A Chou, ... Nature genetics 53 (1), 65-75, 2021 | 408 | 2021 |
| Robust replication of genotype-phenotype associations across multiple diseases in an electronic medical record MD Ritchie, JC Denny, DC Crawford, AH Ramirez, JB Weiner, JM Pulley, ... The American Journal of Human Genetics 86 (4), 560-572, 2010 | 385 | 2010 |
| Evidence for substantial fine-scale variation in recombination rates across the human genome DC Crawford, T Bhangale, N Li, G Hellenthal, MJ Rieder, DA Nickerson, ... Nature genetics 36 (7), 700-706, 2004 | 338 | 2004 |
| Unravelling the human genome-phenome relationship using phenome-wide association studies WS Bush, MT Oetjens, DC Crawford Nature Reviews Genetics 17 (3), 129-145, 2016 | 319 | 2016 |
| Variants near FOXE1 are associated with hypothyroidism and other thyroid conditions: using electronic medical records for genome-and phenome-wide studies JC Denny, DC Crawford, MD Ritchie, SJ Bielinski, MA Basford, Y Bradford, ... The American Journal of Human Genetics 89 (4), 529-542, 2011 | 316 | 2011 |
| Genetic variants associated with warfarin dose in African-American individuals: a genome-wide association study MA Perera, LH Cavallari, NA Limdi, ER Gamazon, A Konkashbaev, ... The Lancet 382 (9894), 790-796, 2013 | 315 | 2013 |
| Generalization and dilution of association results from European GWAS in populations of non-European ancestry: the PAGE study CS Carlson, TC Matise, KE North, CA Haiman, MD Fesinmeyer, S Buyske, ... PLoS Biol 11 (9), e1001661, 2013 | 268 | 2013 |
| Meta-analysis of genome-wide association studies in African Americans provides insights into the genetic architecture of type 2 diabetes MCY Ng, D Shriner, BH Chen, J Li, WM Chen, X Guo, J Liu, SJ Bielinski, ... PLoS Genet 10 (8), e1004517, 2014 | 253 | 2014 |
| Optimizing drug outcomes through pharmacogenetics: a case for preemptive genotyping JS Schildcrout, JC Denny, E Bowton, W Gregg, JM Pulley, MA Basford, ... Clinical Pharmacology & Therapeutics 92 (2), 235-242, 2012 | 213 | 2012 |
| Haplotype diversity across 100 candidate genes for inflammation, lipid metabolism, and blood pressure regulation in two populations DC Crawford, CS Carlson, MJ Rieder, DP Carrington, Q Yi, JD Smith, ... The American Journal of Human Genetics 74 (4), 610-622, 2004 | 213 | 2004 |
Marylyn D RitchieUniversity of PennsylvaniaVerified email at upenn.edu
